Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Schleinitz

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|October 5, 2016
Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) studyVincent Barlogis, Nizar Mahlaoui, Pascal Auquier, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Brain : a Journal of Neurology|April 19, 2016
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibodyYves Allenbach, Jeremy Keraen, Anne-Marie Bouvier, et al.
Critical Care Medicine|October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
The New England Journal of Medicine|November 14, 2024
Inebilizumab for Treatment of IgG4-Related DiseaseJohn H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Frontiers in Immunology|January 23, 2024
Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patientsHubert de Boysson, Marie Cuchet, Charles Cassius, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2019
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related DiseaseZachary S Wallace, Ray P Naden, Suresh Chari, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 22, 2019
"Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free PatientsGuillaume Lefèvre, Amélie Leurs, Jean-Baptiste Gibier, et al.
Medicine|July 26, 2018
Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patientsArsene Mekinian, Lucas Maisonobe, Latifatou Boukari, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|October 5, 2016
Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) studyVincent Barlogis, Nizar Mahlaoui, Pascal Auquier, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Brain : a Journal of Neurology|April 19, 2016
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibodyYves Allenbach, Jeremy Keraen, Anne-Marie Bouvier, et al.
Critical Care Medicine|October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
The New England Journal of Medicine|November 14, 2024
Inebilizumab for Treatment of IgG4-Related DiseaseJohn H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Frontiers in Immunology|January 23, 2024
Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patientsHubert de Boysson, Marie Cuchet, Charles Cassius, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2019
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related DiseaseZachary S Wallace, Ray P Naden, Suresh Chari, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 22, 2019
"Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free PatientsGuillaume Lefèvre, Amélie Leurs, Jean-Baptiste Gibier, et al.
Medicine|July 26, 2018
Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patientsArsene Mekinian, Lucas Maisonobe, Latifatou Boukari, et al.
Pageof 17